Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity.

Nat Commun · 2022 · PMC9652358 · PMID 36369237

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significancep = 0.15not close (p > 0.1)

The average expression level of FOXF2 was lower in the PZ than in those TZ tumors but the difference did not reach statistical significance (expression ratio in PZ versus TZ = 0.59, p = 0.15, t-test).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.